Skip to content

Depression: all studies

Page 356 of 1,036: studies 3,551 to 3,560 of 10,358, newest first. Back to the depression overview

Research

A Systematic Review of Yoga Interventions on the Mental Health of Nursing Professionals and Students

International Journal of Yoga May 5, 2025 Rahul Geeta Arya, Deepsikha Srivastava, B. R. Divya et al.

This systematic review aimed to evaluate the impact of yoga interventions on preventing and alleviating mental health issues, including stress, anxiety, burnout, depression, and other related factors among nursing professionals and students. The review adhered to the PRISMA guidelines and was registered in PROSPERO (CRD42024512366). A comprehensive literature search was conducted in Google...

Ketamine evokes acute behavioral effects via μ-opioid receptor expressing neurons of the central amygdala.

Biological Psychiatry May 5, 2025 Matthew B Pomrenze, Sam Vaillancourt, Pierre Llorach et al. 11 citations

Ketamine has anesthetic, analgesic, and antidepressant properties which may involve multiple neuromodulatory systems. In humans, the opioid receptor (OR) antagonist naltrexone blocks the antidepressant effect of ketamine. This mechanism may differentiate ketamine from other NMDA receptor antagonists. Animal models that reflect OR-dependent behavioral effects of ketamine may shed light on the...

DOI: 10.1016/j.biopsych.2025.04.020 (opens in new tab) Full text (opens in new tab) Antidepressant Central amygdala Mu opioid receptor Naltrexone +5

Role of CaMKII/CREB pathway in rapid-antidepressant-like effect: comparison of ketamine with rapastinel.

Experimental Brain Research May 4, 2025 Ceyda Özler, Esra Özkan, Narges Shomalizadeh et al. 1 citation

Recent studies in mouse models have demonstrated that ketamine and rapastinel induce rapid-acting and sustained antidepressant effects in major depressive disorder (MDD). However, it remains unclear how ketamine's and rapastinel's opposing mechanisms of action-NMDAR antagonist and NMDAR positive allosteric modulator, respectively-result in similar antidepressant-like effects. Furthermore,...

Attitudes and Perceptions of Portuguese Psychiatrists and Psychologists on the Clinical Use of Ketamine.

Acta Médica Portuguesa May 2, 2025 Pedro Mota, Jorge Encantado, Laura C. Carvalho et al. 1 citation

Ketamine has garnered attention for its rapid efficacy in alleviating depressive symptoms in treatment-resistant depression, offering a novel mechanism as a non-monoaminergic agent. Despite its potential, limited research has explored mental health professionals' perspectives on its use. This study assesses the attitudes, knowledge, and concerns of Portuguese psychiatrists and psychologists...

Prophylactic (R,S)-Ketamine and (2S,6S)-Hydroxynorketamine Decrease Fear Expression by Differentially Modulating Fear Neural Ensembles.

Biological Psychiatry May 1, 2025 Alessia Mastrodonato, Michelle Jin, Noelle Kee et al. 5 citations

We previously reported that a single injection of (R,S)-ketamine or its metabolite (2S,6S)-hydroxynorketamine (HNK) prior to stress attenuated learned fear. However, whether these drugs attenuate learned fear through divergent or convergent effects on neural activity remains to be determined. 129S6/SvEv male mice were injected with saline, (R,S)-ketamine, or (2S,6S)-HNK 1 week before a 3-shock...

DOI: 10.1016/j.biopsych.2024.09.024 (opens in new tab) Full text (opens in new tab) Depression Contextual fear conditioning Metabolite Neural network +5

Safety considerations and risk mitigation strategies for ketamine use: a comprehensive review.

Annals of Medicine and Surgery May 1, 2025 Reem Sayad, Ahmed Saad Elsaeidy, Amna M Anis et al. 7 citations

Ketamine, a dissociative anesthetic, has gained widespread use in various medical contexts, including anesthesia, pain management, and treatment-resistant depression. Despite its therapeutic potential, concerns regarding its safety profile have prompted ongoing research and regulatory guidance. This comprehensive literature review explores the current safety considerations of ketamine,...

DOI: 10.1097/MS9.0000000000003232 (opens in new tab) Full text (opens in new tab) Depression Ketamine therapy Mental health treatment Medical safety protocols +2

Royal Australian and New Zealand College of Psychiatrists professional practice guidelines for the use of ketamine in psychiatric practice.

Australian & New Zealand Journal of Psychiatry April 28, 2025 Salam Hussain, Chris Gale, Shanthi Sarma et al. 10 citations

Professional practice guidelines for the use of ketamine in psychiatric practice have been developed by the Royal Australian and New Zealand College of Psychiatrists to provide guidance on the use of ketamine in clinical practice in Australia and Aotearoa New Zealand, based on scientific evidence and supplemented by expert clinical consensus. Articles and information were sourced from existing...

DOI: 10.1177/00048674251333577 (opens in new tab) Full text (opens in new tab) Professional practice Psychiatric disorders Mental health treatment Ketamine therapy +3

Chain mediation of rumination and anxiety state between mindfulness and depressed mood in infertile women.

Scientific Reports April 23, 2025 Shiqi Luo, Biru Luo, Zihang Wei et al. 2 citations

The study aims to explore the relationship between mindfulness, rumination thinking, anxiety state, and depressed mood, and the chain mediating roles of rumination thinking and anxiety state in explaining how mindfulness influences depressed mood in infertile women. This cross-sectional study included 946 women with infertility from a maternal and child hospital in western China through...

Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.

Palliative & Supportive Care April 22, 2025 Maria I Lapid, Sandeep R Pagali, Andrea L Randall et al. 9 citations

Psychological and existential distress is prevalent among patients with life-threatening cancer, significantly impacting their quality of life. Psilocybin-assisted therapy has shown promise in alleviating these symptoms. This systematic review aims to synthesize the evidence on the efficacy and safety of psilocybin in reducing cancer-related distress. We searched MEDLINE, APA PsycINFO, Cochrane...

Benefits of a mindfulness and compassion program for cancer patients: experience in a Spanish public hospital setting.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico April 17, 2025 Marcial Arredondo, Ferran Mestanza, Ruth Carpio et al. 1 citation

Mindfulness-based interventions have been shown to improve the quality of life of cancer patients and are widely recommended. This was a non-randomized, single-center study designed to assess the feasibility and benefits of a mindfulness and compassion program for individuals living with cancer (MCP-C). The primary objective was to evaluate the feasibility of the program, while the secondary...